Paper3300532
Selective gut decontamination with nalidixic acid or trimethoprim-sulfamethoxazole for infection prophylaxis in neutropenic cancer patients: relationship of efficacy to antimicrobial spectrum and timing of administration.
Bow EJ and 3 others. Antimicrob Agents Chemother, 1987. Cited by 26 papers, by iCite.
Cite this record
ConductScience Library. Selective gut decontamination with nalidixic acid or trimethoprim-sulfamethoxazole for infection prophylaxis in neutropenic cancer patients: relationship of efficacy to antimicrobial spectrum and timing of administration. Papers, record 3300532. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3300532
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
Selective gut decontamination with nalidixic acid or trimethoprim-sulfamethoxazole for infection prophylaxis in neutropenic cancer patients: relationship of efficacy to antimicrobial spectrum and timing of administration.
- PubMed
- Publication types
- Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't
- PubMed
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Agranulocytosis | Major topic |
| Bacterial Infections | Major topic |
| Intestines | Major topic |
| Nalidixic Acid | Major topic |
| Neoplasms | Major topic |
| Neutropenia | Major topic |
| Sulfamethoxazole | Major topic |
| Trimethoprim | Major topic |
| Antineoplastic Agents | |
| Bacteria | |
| Clinical Trials as Topic | |
| Drug Administration Schedule | |
| Drug Combinations | |
| Humans | |
| Microbial Sensitivity Tests | |
| Mycoses | |
| Random Allocation | |
| Trimethoprim, Sulfamethoxazole Drug Combination |
Source PubMed
References34
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 3909333 | Preservation of colonization resistance parameters during empiric therapy with aztreonam in the febrile neutropenic patient. | Rev Infect Dis | 1985 | https://conductscience.org/library/papers/3909333 | PubMed |
| 2 | 3890789 | A multicenter comparative trial of tobramycin and ticarcillin vs moxalactam and ticarcillin in febrile neutropenic patients. | Arch Intern Med | 1985 | https://conductscience.org/library/papers/3890789 | PubMed |
| 3 | 5923022 | A critical evaluation of nalidixic acid in urinary-tract infections. | N Engl J Med | 1966 | https://conductscience.org/library/papers/5923022 | PubMed |
| 4 | 4199490 | The effect of a combined preparation of trimethoprim and sulphamethoxazole following short-term and long-term administration on the flora of the human gut. | Chemotherapy | 1973 | https://conductscience.org/library/papers/4199490 | PubMed |
| 5 | 4206836 | Selective elimination of Enterobacteriaceae species from the digestive tract in mice and monkeys. | J Hyg (Lond) | 1974 | https://conductscience.org/library/papers/4206836 | PubMed |
| 6 | 412099 | Successful chemoprophylaxis for Pneumocystis carinii pneumonitis. | N Engl J Med | 1977 | https://conductscience.org/library/papers/412099 | PubMed |
| 7 | 79761 | Co-trimoxazole for prevention of infection in acute leukaemia. | Lancet | 1978 | https://conductscience.org/library/papers/79761 | PubMed |
| 8 | 371396 | A prospective controlled investigation of prophylactic trimethoprim/sulfamethoxazole in hospitalized granulocytopenic patients. | Am J Med | 1979 | https://conductscience.org/library/papers/371396 | PubMed |
| 9 | 6997054 | Infection prevention in granulocytopenic patients by selective decontamination of the digestive tract. | Eur J Cancer (1965) | 1980 | https://conductscience.org/library/papers/6997054 | PubMed |
| 10 | 6110821 | Vi serology in the detection of typhoid carriers. | Lancet | 1981 | https://conductscience.org/library/papers/6110821 | PubMed |
| 11 | 6782486 | A comparison of trimethoprim-sulfamethoxazole plus nystatin with gentamicin plus nystatin in the prevention of infections in acute leukemia. | N Engl J Med | 1981 | https://conductscience.org/library/papers/6782486 | PubMed |
| 12 | 7017019 | Selective antimicrobial modulation of human microbial flora: infection prevention in patients with decreased host defense mechanisms by selective elimination of potentially pathogenic bacteria. | J Infect Dis | 1981 | https://conductscience.org/library/papers/7017019 | PubMed |
| 13 | 7025721 | Prophylactic trimethoprim-sulfamethoxazole during consolidation chemotherapy for acute leukemia: a controlled trial. | Ann Intern Med | 1981 | https://conductscience.org/library/papers/7025721 | PubMed |
| 14 | 6794406 | Prevention of infection by trimethoprim-sulfamethoxazole plus amphotericin B in patients with acute nonlymphocytic leukaemia. | Ann Intern Med | 1981 | https://conductscience.org/library/papers/6794406 | PubMed |
| 15 | 7053467 | Failure of oral trimethoprim-sulfamethoxazole prophylaxis in acute leukemia: isolation of resistant plasmids from strains of Enterobacteriaceae causing bacteremia. | N Engl J Med | 1982 | https://conductscience.org/library/papers/7053467 | PubMed |
| 16 | 7033781 | Emergence of high-level trimethoprim resistance in fecal Escherichia coli during oral administration of trimethoprim or trimethoprim--sulfamethoxazole. | N Engl J Med | 1982 | https://conductscience.org/library/papers/7033781 | PubMed |
| 17 | 6981175 | Trimethoprim-sulfamethoxazole and trimethoprim alone for prophylaxis of infection in granulocytopenic patients. | Rev Infect Dis | 1982 | https://conductscience.org/library/papers/6981175 | PubMed |
| 18 | 7125409 | Staphylococcus epidermidis: an increasing cause of infection in patients with granulocytopenia. | Ann Intern Med | 1982 | https://conductscience.org/library/papers/7125409 | PubMed |
| 19 | 7174858 | Pharmacokinetics of nalidixic acid in old and young volunteers. | J Clin Pharmacol | 1982 | https://conductscience.org/library/papers/7174858 | PubMed |
| 20 | 6336781 | Oral antibiotic prophylaxis in patients with cancer: a double-blind randomized placebo-controlled trial. | J Pediatr | 1983 | https://conductscience.org/library/papers/6336781 | PubMed |
Cited by9
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 26 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39704726 | The effect of combining antibiotics on resistance: A systematic review and meta-analysis. | Elife | 2024 | https://conductscience.org/library/papers/39704726 | PubMed |
| 37597052 | Prevention of ICU-acquired infection with decontamination regimen in immunocompromised patients: a pre/post observational study. | Eur J Clin Microbiol Infect Dis | 2023 | https://conductscience.org/library/papers/37597052 | PubMed |
| 33846857 | Primary prophylaxis of bacterial infections and Pneumocystis jirovecii pneumonia in patients with hematologic malignancies and solid tumors: 2020 updated guidelines of the Infectious Diseases Working Party of the German Society of Hematology and Medical Oncology (AGIHO/DGHO). | Ann Hematol | 2021 | https://conductscience.org/library/papers/33846857 | PubMed |
| 22416197 | Reduction in clinical response to empiric antimicrobial therapy of febrile granulocytopenic patients receiving TMP/SMX infection prophylaxis. | Can J Infect Dis | 1992 | https://conductscience.org/library/papers/22416197 | PubMed |
| 8460916 | Oral enoxacin for infection prevention in adults with acute nonlymphocytic leukemia. The Enoxacin Prophylaxis Study Group. | Antimicrob Agents Chemother | 1993 | https://conductscience.org/library/papers/8460916 | PubMed |
| 8195392 | Evaluation of enzyme immunoassay for Candida cytoplasmic antigens in neutropenic cancer patients. | J Clin Microbiol | 1994 | https://conductscience.org/library/papers/8195392 | PubMed |
| 2686547 | Effects on oral and intestinal microfloras of norfloxacin and pefloxacin for selective decontamination in bone marrow transplant patients. | Antimicrob Agents Chemother | 1989 | https://conductscience.org/library/papers/2686547 | PubMed |
| 2680058 | Fluoroquinolone antimicrobial agents. | Clin Microbiol Rev | 1989 | https://conductscience.org/library/papers/2680058 | PubMed |
| 2327768 | Ofloxacin versus co-trimoxazole for prevention of infection in neutropenic patients following cytotoxic chemotherapy. | Antimicrob Agents Chemother | 1990 | https://conductscience.org/library/papers/2327768 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3300532
GET https://conductscience.org/api/papers/v1/3300532/references?page=2